UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016991
Receipt No. R000019718
Scientific Title Phase II trial (Investigator-initiated clinical trial) of CH5424802 in patients with relapsed or refractory ALK-positive anaplastic large cell lymphoma
Date of disclosure of the study information 2015/04/01
Last modified on 2019/04/03 09:12:35

No. Disposal Last modified on Item of update
1 Insert 2015/03/31 17:43:00
2 Update 2015/08/05 09:06:50 Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
Nationality of Funding Organization
3 Update 2016/01/26 10:21:14 Organization
Organization
4 Update 2016/04/22 15:50:31 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
5 Update 2016/04/22 15:51:41 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2017/07/25 09:49:11 UMIN ID1
7 Update 2017/07/25 09:50:12 Recruitment status
8 Update 2017/07/25 09:53:38 Name of primary sponsor
Organization
9 Update 2017/10/02 09:13:52 Last follow-up date
10 Update 2018/05/02 09:08:12 Date trial data considered complete
11 Update 2018/06/27 14:02:23 Institute
Institute
Organization
Organization
12 Update 2019/04/03 09:08:59 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
13 Update 2019/04/03 09:10:46 Number of participants that the trial has enrolled
Results
Results
Results date posted
14 Update 2019/04/03 09:12:35 Date of IRB


Contact us.